Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Calcilate-D is an approved combination product developed by Achilles Healthcare, formulated to support bone health and mineral homeostasis. It contains calcium citrate malate, a water-soluble calcium source known for its high bioavailability compared to other calcium salts, and vitamin D3 (cholecalciferol). Calcium is a critical structural component of bone tissue, while vitamin D3 acts as a precursor to calcitriol, which binds to the vitamin D receptor (VDR) to enhance intestinal calcium absorption and regulate renal calcium excretion. This product is primarily used for the treatment and prevention of calcium and vitamin D deficiencies, and as an adjunct therapy for osteoporosis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on calcium citrate malate + cholecalciferol.